How Much Did Spine Wave Raise?
Funding & Key Investors

Spine Wave has established a robust financial foundation through a series of strategic capital infusions, culminating in a total historical backing of $155.8M. The company recently secured a major strategic investment of $2M, reinforcing its market position as a developer of advanced spinal surgical technologies. This latest injection of capital underscores the firm's ongoing commitment to scaling its operations and expanding its reach within the competitive medical device landscape.

The company's growth trajectory, marked by multiple rounds of financing from inception to its current mature stage, reflects sustained investor confidence in its proprietary expandable fusion platforms and comprehensive product portfolio.

What is Spine Wave?

Spine Wave
ManufacturingMedical Devices & Equipment

Spine Wave operates at the forefront of the medical technology sector, specializing in the design and commercialization of expandable fusion devices and minimally invasive surgical solutions. By addressing the complex needs of spine surgeons and their patients, the company has built a diverse ecosystem of products, including the Leva Interbody Device and the GraftMag Graft Delivery System. Its market strategy centers on delivering highly differentiated, clinically validated technologies that improve patient outcomes while streamlining surgical workflows. As a key player in the musculoskeletal space, Spine Wave continues to leverage its technical expertise to capture market share and drive innovation in spinal care.

How much funding has Spine Wave raised?

Spine Wave has raised a total of $155.8M across 9 funding rounds:

2003

Series B

$22.3M

2006

Series C

$36.5M

2007

Series D

$45M

2011

Series E

$17.6M

2016

Debt

$4.4M

Other Financing Round

$11M

2020

Debt

$2M

2021

Debt

$2M

Series B (2003): $22.3M led by Canaan Partners, California Technology Ventures, LLC, Thoma Cressey Equity Partners, Morgenthaler Private Equity, Collinson Howe & Lennox, New Venture Partners, New Enterprise Associates, and NeuroVentures Capital

Series C (2006): $36.5M supported by Morgenthaler Venture Partners, CHL Medical Partners, New Enterprise Associates, Canaan Partners, Thoma Cressey Equity Partners, California Technology Partners, Foundation Medical Partners, and Sprout Capital

Series D (2007): $45M featuring Canaan Partners, Thoma Cressy Equity Partners, Inc, California Technology Partners, Foundation Medical Partners, Morgenthaler Private Equity, CHL Medical Partners, New Enterprise Associates, and Sprout Group

Series E (2011): $17.6M backed by New Leaf Venture Partners, Morgenthaler Private Equity, Canaan Partners, Foundation Medical Partners, and New Enterprise Associates

Debt (2016): $4.4M with participation from California Technology Partners, New Enterprise Associates, MB Ventures, and Industry Ventures

Other Financing Round (2016): $11M led by MB Venture Partners, California Technology Ventures, LLC, Collinson Group, and Acadia Woods Partners

Debt (2020): $2M supported by PPP

Debt (2021): $2M featuring PPP

Key Investors in Spine Wave

New Enterprise Associates

Established in 1977 and headquartered in Menlo Park, California, New Enterprise Associates is a prominent venture capital firm focused on helping entrepreneurs build transformative businesses.

Canaan Partners

Canaan is an early-stage venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as biopharma and digital health.

Morgenthaler Private Equity

Morgenthaler is a premier venture capital and private equity firm with over 40 years of experience, specializing in investments within the Information Technology and Life Sciences sectors.

What's next for Spine Wave?

With the support of its long-term investment partners, Spine Wave is well-positioned to accelerate its commercial expansion and deepen its penetration in the global spine market. The company's strategic roadmap focuses on the continued recruitment of high-caliber sales leadership and the expansion of its independent distributor network to support the adoption of its latest surgical systems. By maintaining a focus on R&D and operational excellence, Spine Wave aims to solidify its status as a leader in the development of next-generation spinal fusion technologies, ensuring that its portfolio remains at the cutting edge of clinical practice.

See full Spine Wave company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Health & Nutrition ProductsManufacturingRetailVitamins, Supplements & Health Stores
Industrial Machinery & EquipmentManufacturingAutomotive Parts
Building MaterialsManufacturingFurniture
ManufacturingTest & Measurement EquipmentIndustrial Machinery & Equipment

Frequently Asked Questions Regarding Spine Wave Financial Insights

What are the most recent funding rounds that Spine Wave has completed, and what were the funding rounds?
Spine Wave has recently completed 3 funding rounds: Debt on Mar 8, 2021, Debt on Apr 15, 2020, Other Financing Round on May 30, 2016.
What is the total amount of funding Spine Wave has raised to date?
Spine Wave has raised a total of $155.8M in funding to date.
How many funding rounds has Spine Wave completed?
Spine Wave has completed 3 funding rounds.
How much funding did Spine Wave raise in its most recent funding round?
Spine Wave raised $2M in its most recent funding round.
Who are the lead investors in Spine Wave's latest funding round?
The lead investor in Spine Wave's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Spine Wave's history?
The largest funding round in Spine Wave's history was $45M.
See more information about Spine Wave